BC264
BC264 is a highly potent and selective CCK-B agonist that crosses the blood-brain barrier. BC264 increases dopamine in the nucleus accumbens and facilitates motivation and attention in rats[1].
Product Specifications
UNSPSC
12352211
Target
Cholecystokinin Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Neurological Disease
Smiles
NC([C@H](CC1=CC=CC=C1)NC([C@H](CC(O)=O)NC([C@H](CCCC)N(C)C([C@@H](NC(CNC([C@H](CCCC)NC([C@H](CCSC)NC([C@H](CC2=CC=C(S(=O)(O)=O)C=C2)NC(OC(C)(C)C)=O)=O)=O)=O)=O)CC3=CNC4=C3C=CC=C4)=O)=O)=O)=O
Molecular Formula
C58H80N10O15S2
Molecular Weight
1221.44
References & Citations
[1]Ladurelle N, et al. The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats. Eur J Neurosci. 1997 Sep;9 (9) :1804-14.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CCKBR
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6461572-01 0.1 mL
ADCY2, CT (Adenylate Cyclase Type 2, Adenylate Cyclase Type II, ATP Pyrophosphate-lyase 2, Adenylyl Cyclase 2, ADCY2, KIAA1060) (MaxLight 550)
Ask
View Details 
MBS6461572-02 5x 0.1 mL
ADCY2, CT (Adenylate Cyclase Type 2, Adenylate Cyclase Type II, ATP Pyrophosphate-lyase 2, Adenylyl Cyclase 2, ADCY2, KIAA1060) (MaxLight 550)
Ask
View Details GTR15098915 1 Vial
Lentiviral human RPTOR shRNA (UAS) - Lentiviral human RPTOR shRNA (UAS, RFP) (25)
Ask
View Details 